In:
The Journal of Immunology, The American Association of Immunologists, Vol. 180, No. 4 ( 2008-02-15), p. 2062-2068
Abstract:
Multiple studies have demonstrated that 4-1BB (CD137), a member of the TNF receptor superfamily, is expressed on several immune cells including activated T cells. However, the expression and the role of 4-1BB on natural killer T (NKT) cells have not been fully characterized. In this study, it was shown that 4-1BB was not expressed on naive NKT cells but was rapidly induced on activated NKT cells by TCR engagement with α-galactosylceramide (α-GalCer). Also, 4-1BB signaling provided by 3H3, an agonistic anti-4-1BB mAb, promoted NKT cell activation resulting in enhanced cytokine production of NKT cells driven by α-GalCer. When NKT cell-driven airway immune responses were evaluated by intranasal administration of α-GalCer, airway hyperresponsiveness (AHR) and lung inflammation were significantly more aggravated in mice treated with 3H3 and α-GalCer than in mice treated with α-GalCer alone. These aggravations were accompanied by up-regulation of IL-4, IL-13, and IFN-γ production. Interestingly, AHR was not developed in IL-4Rα-deficient mice treated with α-GalCer with or without 3H3 but was exacerbated in IFN-γ-deficient mice. Our study suggests that 4-1BB on NKT cells functions as a costimulatory molecule and exacerbates the induction of NKT cell-mediated AHR, which is dependent on the IL-4Rα-mediated pathway.
Type of Medium:
Online Resource
ISSN:
0022-1767
,
1550-6606
DOI:
10.4049/jimmunol.180.4.2062
Language:
English
Publisher:
The American Association of Immunologists
Publication Date:
2008
detail.hit.zdb_id:
1475085-5
Permalink